McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
CRL holding history
Charles River Laboratories International, Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRL overviewAll 13F holders of CRLFull Q1 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −25−100.0% | Sold out | Holders |
| Q4 2024 | 25 | $4.62K | <0.1% | −10−28.6% | Reduced | Holders |
| Q3 2024 | 35 | $6.89K | <0.1% | +35 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −28−100.0% | Sold out | Holders |
| Q1 2024 | 28 | $7.59K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 28 | $6.62K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 28 | $5.49K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 28 | $5.89K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 28 | $5.65K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 28 | $6.10K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 28 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 28 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 28 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 28 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 28 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 28 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 28 | $8.00K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.